Diploma PLC (LON:DPLM) Insider Acquires £2,141.48 in Stock

Diploma PLC (LON:DPLM) insider Katie Bickerstaffe acquired 44 shares of the firm’s stock in a transaction dated Wednesday, May 21st. The stock was bought at an average price of GBX 4,867 ($65.27) per share, for a total transaction of £2,141.48 ($2,871.77).

Katie Bickerstaffe also recently made the following trade(s):

• On Tuesday, May 20th, Katie Bickerstaffe acquired 39 shares of Diploma stock. The stock was bought at an average price of GBX 4,981 ($66.80) per share, for a total transaction of £1,942.59 ($2,605.06).
• On Tuesday, May 20th, Katie Bickerstaffe bought 13 shares of Diploma stock. The shares were acquired at an average price of GBX 4,982 ($66.81) per share, for a total transaction of £647.66 ($868.53).

Diploma Stock Performance

LON:DPLM opened at GBX 4,802 ($64.40) on Thursday. Diploma PLC has a 52 week low of GBX 3,532 ($47.36) and a 52 week high of GBX 5,025 ($67.39). The company has a fifty day simple moving average of GBX 3,967.56 and a two-hundred day simple moving average of GBX 4,257.56. The company has a quick ratio of 0.80, a current ratio of 2.17 and a debt-to-equity ratio of 62.17. The company has a market cap of £6.40 billion, a price-to-earnings ratio of 55.20, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75.

Diploma (LON:DPLM) last posted its quarterly earnings data on Wednesday, May 21st. The company reported GBX 80.20 ($1.08) earnings per share for the quarter. Diploma had a return on equity of 13.18% and a net margin of 9.25%. As a group, equities analysts anticipate that Diploma PLC will post 163.7995512 earnings per share for the current fiscal year.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.